Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Fulcrum Therapeutics (FULC) has disclosed Receivables - Net for 3 consecutive years, with $13000.0 as the latest value for Q3 2022.

  • Quarterly Receivables - Net changed N/A to $13000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $13000.0 through Sep 2022, changed N/A year-over-year, with the annual reading at $2.5 million for FY2021, 124900.0% up from the prior year.
  • Receivables - Net for Q3 2022 was $13000.0 at Fulcrum Therapeutics, down from $357000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $2.5 million in Q4 2021, with the low at $13000.0 in Q3 2022.
  • Average Receivables - Net over 3 years is $1.2 million, with a median of $1.2 million recorded in 2020.
  • Peak annual rise in Receivables - Net hit 25.0% in 2021, while the deepest fall reached 25.0% in 2021.
  • Over 3 years, Receivables - Net stood at $2.0 million in 2020, then grew by 25.0% to $2.5 million in 2021, then tumbled by 99.48% to $13000.0 in 2022.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $13000.0, $357000.0, and $2.5 million for Q3 2022, Q2 2022, and Q4 2021 respectively.